15 insiders reported 163 Form 4 transactions for AGIOS PHARMACEUTICALS, INC. (AGIO) over the past 18 months (most recent 2026-07-02). Recent activity: Gheuens Sarah (Chief Medical Officer) Buy 8,375 shares, Gheuens Sarah (Chief Medical Officer) Sell 4,007 shares, CAPELLO JEFFREY D (Director) Buy 2,816 shares, Foster-Cheek Kaye I (Director) Buy 2,816 shares, FOUSE JACQUALYN A (Director) Buy 2,816 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Gheuens Sarah | Chief Medical Officer | Buy | 8,375 | $0 |
| 2026-07-02 | Gheuens Sarah | Chief Medical Officer | Sell | 4,007 | $150,503 |
| 2026-06-23 | CAPELLO JEFFREY D | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Foster-Cheek Kaye I | Director | Buy | 2,816 | $0 |
| 2026-06-23 | FOUSE JACQUALYN A | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Smith Cynthia | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Ho Maykin | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Scadden David | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Ballal Rahul D. | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Owen Adams Catherine | Director | Buy | 2,816 | $0 |
| 2026-06-16 | CAPELLO JEFFREY D | Director | Buy | 1,976 | $0 |
| 2026-06-16 | Owen Adams Catherine | Director | Buy | 1,976 | $0 |
| 2026-04-06 | Jones Cecilia | Chief Financial Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Gheuens Sarah | Chief Medical Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Burns James William | Chief Legal Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Buy | 25,528 | $0 |
| 2026-04-06 | Milanova Tsveta | Chief Commercial Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | Buy | 8,100 | $0 |
| 2026-04-06 | Burns James William | Chief Legal Officer | Sell | 3,280 | $113,849 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Sell | 12,472 | $432,903 |
| 2026-04-06 | Jones Cecilia | Chief Financial Officer | Sell | 3,141 | $109,024 |
| 2026-04-06 | Gheuens Sarah | Chief Medical Officer | Sell | 2,940 | $102,047 |
| 2026-04-06 | Milanova Tsveta | Chief Commercial Officer | Sell | 3,262 | $113,224 |
| 2026-04-06 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | Sell | 2,959 | $102,707 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Buy | 13,500 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02